CLOV34 Stock Overview
Clover Health Investments, Corp. provides medicare advantage plans in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Clover Health Investments, Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.46 |
| 52 Week High | US$7.72 |
| 52 Week Low | US$3.19 |
| Beta | 1.85 |
| 1 Month Change | -5.21% |
| 3 Month Change | -27.00% |
| 1 Year Change | -6.99% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -70.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| CLOV34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 5.5% | 2.8% | 0.9% |
| 1Y | -7.0% | 2.9% | 15.2% |
Return vs Industry: CLOV34 underperformed the BR Healthcare industry which returned 2.9% over the past year.
Return vs Market: CLOV34 underperformed the BR Market which returned 15.2% over the past year.
Price Volatility
| CLOV34 volatility | |
|---|---|
| CLOV34 Average Weekly Movement | 6.8% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in BR Market | 9.0% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: CLOV34's share price has been volatile over the past 3 months.
Volatility Over Time: CLOV34's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 552 | Andrew Toy | www.cloverhealth.com/en/ |
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Clover Health Investments, Corp. Fundamentals Summary
| CLOV34 fundamental statistics | |
|---|---|
| Market cap | R$1.75b |
| Earnings (TTM) | -R$1.08b |
| Revenue (TTM) | R$10.32b |
0.2x
P/S Ratio-1.6x
P/E RatioIs CLOV34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLOV34 income statement (TTM) | |
|---|---|
| Revenue | US$2.04b |
| Cost of Revenue | US$1.78b |
| Gross Profit | US$259.85m |
| Other Expenses | US$473.21m |
| Earnings | -US$213.36m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | -0.43 |
| Gross Margin | 12.76% |
| Net Profit Margin | -10.48% |
| Debt/Equity Ratio | 0% |
How did CLOV34 perform over the long term?
See historical performance and comparison